Time to put this in practice folks. Use of low-dose #aspirin as #primaryprevention in older adults resulted in a higher risk of hemorrhage and no lower risk of cardiovascular disease than placebo https://t.co/N2OPi07M4O
“The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major hemorrhage & did not result in a significantly lower risk of cardiovascular disease than placebo.” @NEJM study conclusion on
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @TJaredBunch: OTC ASA is so commonly used and marketed in the elderly as a “healthy” choice, data continues to show no benefit https:/…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/Z46Da8u2ss
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @Bloodman: Another trial showing no role for ASA in primary prevention in the current era of statins and other risk factor reduction htt…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @TJaredBunch: OTC ASA is so commonly used and marketed in the elderly as a “healthy” choice, data continues to show no benefit https:/…
Interesting study!! What are your feelings on this? https://t.co/KsrlsWXN0h
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/hZ0KtLjIug
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/IuI9skXnOA
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
OTC ASA is so commonly used and marketed in the elderly as a “healthy” choice, data continues to show no benefit https://t.co/PzfjP6HaKU
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/I7yAQkggii
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @EricTopol: The results on lack of any cardiovascular benefit but increase in bleeding https://t.co/102822NSxC @NEJM https://t.co/9QhEwY…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @Drlipid: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ErinMichos: This null result was for CV events, similar to #ARRIVE. In #ASPREE, a primary prevention RCT of older adults free of known…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ErinMichos: This null result was for CV events, similar to #ARRIVE. In #ASPREE, a primary prevention RCT of older adults free of known…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @sophwall: Congratulations to John McNeil and the ASPREE team. An amazing an important achievement. https://t.co/K7MeIeQSFg
Congratulations to John McNeil and the ASPREE team. An amazing an important achievement.
がんの再発予防としての低用量アスピリンの臨床試験も多々進行していたような…。。アスピリンの今後は如何に。
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @Curseen: The use of low-dose aspirin as a primary prevention strategy in older adults resulted in a significantly higher risk of major…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @emas_online: Effect of #Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly: study in 20,000 people showed low-dose as…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @DrMorgentaler: Now aspirin is no good? NEJM RCT shows no CV benefit, and increased major hemorrhagic events vs placebo. I’ve always hat…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/KhP1k8Gfn5
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
Surprising and not surprising
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @connors_md: an excellent study answering a question from patients that comes up all the time--should I take aspirin? Effect of Aspirin…
【米国、豪州、高齢者19114名ランダム化、4.7年観察 ”ASPREE”:アスピリン100mg/日で、大出血発生率は8.6/1000例・年。対プラセボ [6.2/1000例・年] HRは1.38 [95%CI 1.18-1.62]。CVイベントは10.7 vs. 11.3でHR 0.95 [0.83-1.08]】 NEJM https://t.co/Zdm8eGLiTT
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @emas_online: Effect of #Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly: study in 20,000 people showed low-dose as…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…